Achieve Life Sciences
ACHV
52 hedge funds and large institutions have $26.2M invested in Achieve Life Sciences in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 24 reducing their positions, and 15 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less funds holding
Funds holding: 63 → 52 (-11)
38% less capital invested
Capital invested by funds: $42.3M → $26.2M (-$16.2M)
63% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 24
65% less call options, than puts
Call options by funds: $152K | Put options by funds: $437K
73% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
BlackRock Group
London,
United Kingdom
|
+$743K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$403K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$368K |
| 4 |
Goldman Sachs
New York
|
+$320K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$264K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.03M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.01M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$736K |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$632K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$583K |
ACHV Hedge Fund Activity: Q3 2014 in Review
52 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2014, worth a combined $26.2M — down 38% from $42.3M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ACHV and 4 opened new positions — a net loss of 11 holders — while 24 trimmed existing stakes and 9 added.
The largest buyer was BlackRock Group, adding an estimated $743K. The largest seller was Millennium Management, cutting an estimated $1.03M.
- 52 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2014, down from 63 in Q2 2014.
- Funds reported $26.2M of Achieve Life Sciences stock for Q3 2014, down 38% quarter-over-quarter.
- 4 funds opened new Achieve Life Sciences positions in Q3 2014 and 15 closed out, a net change of -11 holders.
- The largest Achieve Life Sciences buyer in Q3 2014 was BlackRock Group, an estimated $743K added.
- The largest Achieve Life Sciences seller in Q3 2014 was Millennium Management, an estimated $1.03M sold.
Based on aggregated 13F filings for Q3 2014.